Recovery from withdrawal of inhaled nitric oxide and kinetics of nitric oxide-induced inhibition of nitric oxide synthase activity in vitro

Citation
J. Dotsch et al., Recovery from withdrawal of inhaled nitric oxide and kinetics of nitric oxide-induced inhibition of nitric oxide synthase activity in vitro, INTEN CAR M, 26(3), 2000, pp. 330-335
Citations number
31
Categorie Soggetti
Aneshtesia & Intensive Care
Journal title
INTENSIVE CARE MEDICINE
ISSN journal
03424642 → ACNP
Volume
26
Issue
3
Year of publication
2000
Pages
330 - 335
Database
ISI
SICI code
0342-4642(200003)26:3<330:RFWOIN>2.0.ZU;2-9
Abstract
Objective: To examine the kinetics of successful nitric oxide (NO) withdraw al in vivo and in vitro. Design and setting: Prospective study in a university pediatric intensive c are ward and research laboratory. Patients and materials: Nineteen patients with acute respiratory distress s yndrome (ARDS) or persistent pulmonary hypertension of the newborn (PPHN). Primary porcine pulmonary artery cells in vitro. Interventions: NO inhalation and withdrawal in patients; exposure to NO don or sodium nitroprusside (SNP) and gaseous NO in vitro. Measurements and results: In patients: a slight, but significant, increase of oxygenation index (OI) from 4.57 +/- 0.24 cmH(2)O/torr (mean +/- SEM) to 4.90 +/- 0.26 cmH(2)O/torr after withdrawal of NO (p < 0.001). Recovery of OI (4.43 +/- 0.23 cmH(2)O/torr) 30 min after weaning, a significant drop a fter 4 h (3.72 +/- 0.17 cmH(2)O/ torr; p < 0.001), values restored after 12 h. In vitro: NO synthase (NOS) activity was significantly lower in SNP-incubat ed cells (20.0 +/- 4.0 mu M/min) than in control cells (37.6 +/- 7.0 mu M/ min; p < 0.05). Thirty minutes after SNP withdrawal there was NOS activity of 35.8 +/- 10.0 mu M/min with a significant increase by 4 h (p < 0.05). No alteration of endothelial NOS (ENOS) mRNA expression by NO (Northern Blot) . Conclusion: In patients there is a slight, but significant, reversible incr ease of OI after successful weaning from NO. In vitro, NO leads to a revers ible decrease of ENOS activity on a post mRNA level, resembling clinical ob servations.